Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP)
Titel:
Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP)
Auteur:
Fensterer, H. Schade-Brittinger, C. Müller, H.-H. Tebbe, S. Fass, J. Lindig, U. Settmacher, U. Schmidt, W.E. Märten, A. Ebert, M.P. Kornmann, M. Hofheinz, R. Endlicher, E. Brendel, C. Barth, P.J. Bartsch, D.K. Michl, P. Gress, T.M.